405 results
Page 8 of 21
8-K
EX-4.2
et7747ja9k kl3cqubh
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-4.3
iaj 07umi456ak
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
424B5
fiwwjlxyxvkm3
19 Sep 19
Prospectus supplement for primary offering
5:18pm
FWP
vvt6i7xbkjru
17 Sep 19
Free writing prospectus
4:11pm
8-K
tjnjrm34d
16 Sep 19
Regulation FD Disclosure
7:57am
424B3
uekvb41
16 Sep 19
Prospectus supplement
6:14am
8-K
EX-99.3
lakm 5wctc6485x6
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
ol94rtd4rnq5r cly
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
EX-99.2
4ogze5 b0
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
EX-99.1
4qt54rptf6wrc87sshke
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
EX-10.1
igs8up71v0 ku546yjks
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-99.1
nzfentl uy3dv2
26 Jul 19
AbbVie Reports Second-Quarter 2019 Financial Results
7:44am
8-K
q1p9 rz058a
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
bbp 3zlu310lb
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
5ow45a8kvjcd7w
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
r23r6ifqmvez2et6s
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-2.1
9ibfvr
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-2.3
op9bc
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm